Q32 Bio reports Phase 2a trial results for alopecia areata drug

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/17/2026

1. SPY
2. FLNC
3. CRM
4. GNRC
5. CRWV
6. LMT
7. NVDA
8. USO
9. TLT
10. AMZN

Go back to Q32 Bio reports Phase 2a trial results for alopecia areata drug
(NASDAQ: QTTB) Delayed: 10.86 -0.12 (1.09%)
Previous Close $10.98    52 Week High $ 
Open $11.14    52 Week Low $ 
Day High $11.17    P/E N/A 
Day Low $10.69    EPS $ 
Volume 383,459